[1]中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 慢性鼻窦炎诊断和治疗指南(2024)[J]. 中华耳鼻咽喉头颈外科杂志, 2025, 60(3): 221-249.
[2]Wang M, Li Y, Li J Y, et al. New insights into the endotypes of chronic rhinosinusitis in the biologic era[J]. J Allergy Clin Immunol, 2025, 156(1): 51-60.
[3]Park J, Jang J Y, Kim J H, et al. SLC27A2 marks lipid peroxidation in nasal epithelial cells driven by type 2 inflammation in chronic rhinosinusitis with nasal polyps[J]. Exp Mol Med, 2025, 57(4): 856-871.
[4]Li Y, Liang S, Wang H Q, et al. Type 2 inflammation-biased arachidonic acid metabolite regulates mucosal remodeling of chronic rhinosinusitis with nasal polyps[J]. Allergy, 2026, 81(5): 1680-1696.
[5]中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(2): 81-100.
[6]蓝凤, 赵丽敏, 杨萌哲, 等. 2型和非2型慢性鼻窦炎不伴鼻息肉的临床特征及组织重塑分析[J]. 中国耳鼻咽喉头颈外科, 2022, 29(5): 304-308.
[7]蓝凤, 王麒淇, 张罗. 慢性鼻窦炎伴鼻息肉鼻黏膜上皮细胞基因转录组分析[J]. 中华耳鼻咽喉头颈外科杂志, 2021, 56(10): 1066-1072.
[8]史剑波, 程雷, 李华斌, 等. 2型慢性鼻窦炎临床诊疗意见书[J]. 中华耳鼻咽喉头颈外科杂志, 2024, 59(10): 990-1001.
[9]Lan F, Li J Z, Miao W X, et al. GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases[J]. Nature, 2025, 638(8050): 490-498.
[10]Guo C L, Wang C S, Wang Z C, et al. Granzyme K+CD8+ T cells interact with fibroblasts to promote neutrophilic inflammation in nasal polyps[J]. Nat Commun, 2024, 15(1): 10413.
[11]Chapurin N, Soler Z M, Khan S, et al. Type 2 biomarkers in olfactory cleft mucus correlate with SNOT-22 in chronic rhinosinusitis Independent of nasal polyp status[J]. Int Forum Allergy Rhinol, 2025, 15(4): 411-419.
[12]Schirinzi T, Lattanzi R, Maftei D, et al. Substance P and prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction[J]. Brain Behav Immun, 2023, 108: 302-308.
[13]Perner C, Flayer C H, Zhu X P, et al. Substance P release by sensory neurons triggers dendritic cell migration and initiates the type-2 immune response to allergens[J]. Immunity, 2020, 53(5): 1063-1077.e7.
[14]Maghni K, Taha R, Afif W, et al. Dichotomy between neurokinin receptor actions in modulating allergic airway responses in an animal model of helper T cell type 2 cytokine-associated inflammation[J]. Am J Respir Crit Care Med, 2000, 162(3): 1068-1074.
[15]Nagasaki T, Schuyler A J, Zhao J M, et al. 15LO1 dictates glutathione redox changes in asthmatic airway epithelium to worsen type 2 inflammation[J]. J Clin Invest, 2022, 132(1): e151685.
[16]Wang W Q, Xu Y, Wang L, et al. Single-cell profiling identifies mechanisms of inflammatory heterogeneity in chronic rhinosinusitis[J]. Nat Immunol, 2022, 23(10): 1484-1494.[17]Zheng B, Berrie C P, Corda D, et al. GDE1/MIR16 is a glycerophosphoinositol phosphodiesterase regulated by stimulation of G protein-coupled receptors[J]. Proc Natl Acad Sci U S A, 2003, 100(4): 1745-1750.
[18]Lee E J, Hwang H J, Jung C M, et al. The relationship between chronic rhinosinusitis and metabolic syndrome[J]. Am J Rhinol Allergy, 2017, 31(4): 222-227.
[19]Yagyu H, Kiuchi M, Sasaki A, et al. Lipolysis-microlipophagy cascade regulated by adipose triglyceride lipase drives pathogenic adaptive type 2 immunity[J]. Sci Immunol, 2025, 10(112): eadp0849.
[20]Karagiannis F, Masouleh S K, Wunderling K, et al. Lipid-droplet formation drives pathogenic group 2 innate lymphoid cells in airway inflammation[J]. Immunity, 2020, 52(4): 620-634.e6.
[21]Chen S Y, Aisyah R, Honda A, et al. Overexpression of GDE1 decreases glycerophosphoinositol in intestinal epithelial cells in vivo[J]. Biosci Biotechnol Biochem, 2025, 89(9): 1312-1319.
[22]Simon G M, Cravatt B F. Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain[J]. J Biol Chem, 2008, 283(14): 9341-9349.
|